newsfilter
← Latest News
Bloomberg·

Bristol-Myers to Buy Heart-Drug Maker MyoKardia for $13 Billion

Bristol-Myers Squibb Co. will buy MyoKardia Inc. in a deal valued at $13.1 billion in cash to expand its offering of heart drugs.